LT6001
Neurological Disorder
Pre‑clinicalActive
Key Facts
About Lumosa Therapeutics
Taiwan biotech advancing breakthrough stroke and pain therapies with a strong licensing and co‑development model.
View full company profileTherapeutic Areas
Other Neurological Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| KCC2 Program | Lunai Bioworks | Discovery |